Skip to main content

Sigma-Aldrich CEO to Step Down in January; COO Nagarkatti to Take Helm

NEW YORK, Nov. 9 (GenomeWeb News) - Sigma-Aldrich Chairman and CEO and chairman David Harvey will step down as chief execxutive in January, the company said yesterday.

 

Jai Nagarkatti, the company's sitting president and chief operating officer, will take over as president and CEO beginning Jan. 1, the company said. Harvey will remain as chairman. Nagarkatti was also elected to the board.

 

According to the St. Louis-based life sciences company Nagarkatti has been with Sigma-Aldrich for nearly 30 years, holding positions in R&D, production, operations, and sales and marketing. He has been serving as COO and president since August 2004.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.